
Prof. Theocharis Ispoglou
@theo_ispoglou
Specialising in Exercise and Nutrition Science Research, with a focus on sarcopenia/muscle health. Views are my own
ID: 2518018117
http://www.leedsbeckett.ac.uk/staff/dr-theocharis-ispoglou/ 23-05-2014 14:46:06
1,1K Tweet
1,1K Followers
1,1K Following



(major) Sex differences in dose-response of VILPA (vigorous intermitent l/style #PhysicalActivity) with CVD events New UK Biobank study in British Journal of Sports Medicine (BJSM) bjsm.bmj.com/content/early/… 🙏Matthew Ahmadi Raaj Kishore Biswas Mark Hamer Jason Gill Angelo Sabag Cecilie Thøgersen Borja del Pozo Cruz


Menstrual cycle phase does not influence muscle protein synthesis or whole-body myofibrillar proteolysis in response to resistance exercise New from Lauren Colenso-Semple, PhD James McKendry, Ph.D. Changhyun Lim Stuart Phillips (he/him) doi.org/10.1113/JP2873…


I was excited to see this study posted. I just finished preparing my thread and I guess it's only fair that the author beat me to it! So, to not repeat what Prof. Theocharis Ispoglou shared, I'll add just a few extra tweets that I found interesting. Here's my mini supplemental 🧵

Happy to share our recent work on acute sarcopenia and its impact on muscle mass, strength, and function during hospitalisation "Acute Sarcopenia: Systematic Review and Meta-Analysis on Its Incidence and Muscle Parameter Shifts During Hospitalisation" onlinelibrary.wiley.com/doi/full/10.10…

#Sarcopenia in #hospital ▶️Handgrip #strength & #muscle function tests may not be sensitive enough to identify acute changes ▶️Overall incidence 18% but varies considerably ▶️Can develop rapidly, as quickly as 4 days 👉🏽onlinelibrary.wiley.com/doi/10.1002/jc… via Journal of Cachexia, Sarcopenia and Muscle



Join us for a dynamic day of #HealthInnovation focused on making #LifelongHealth a reality for everyone at ACTLIFE Conference 2025! Check out the programme & register for free: bit.ly/ACTLIFE2025 Thank you to our sponsors Shimadzu UK Limited & Health Innovation Yorkshire & Humber #ACTLIFE2025
